Original article
Impact of proactive of infliximab monitoring using the Bayesian approach in the maintenance phase in patients with inflammatory bowel disease
Impacto de la monitorización proactiva de infliximab en fase de mantenimiento mediante estimación bayesiana en pacientes con enfermedad inflamatoria intestinal
Lidia Serrano Díaz
, Carles Iniesta Navalón, Rosa Gómez Espín, Isabel Nicolás de Prado, Lorena Rentero Redondo
Corresponding author
Hospital General Universitario Reina Sofía, Murcia, Spain
Read
404
Timeswas read the article
129
Total PDF
275
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 December | 5 | 5 | 10 |
| 2024 November | 6 | 4 | 10 |
| 2024 October | 9 | 4 | 13 |
| 2024 September | 4 | 3 | 7 |
| 2024 July | 2 | 0 | 2 |
| 2024 June | 13 | 7 | 20 |
| 2024 May | 16 | 7 | 23 |
| 2024 April | 9 | 10 | 19 |
| 2024 March | 11 | 9 | 20 |
| 2024 February | 11 | 3 | 14 |
| 2024 January | 11 | 0 | 11 |
| 2023 December | 10 | 0 | 10 |
| 2023 November | 11 | 0 | 11 |
| 2023 October | 30 | 8 | 38 |
| 2023 September | 56 | 3 | 59 |
| 2023 August | 31 | 6 | 37 |
| 2023 July | 22 | 6 | 28 |
| 2023 June | 11 | 3 | 14 |
| 2023 May | 3 | 0 | 3 |
| 2023 April | 4 | 5 | 9 |
| 2023 March | 0 | 13 | 13 |
| 2023 February | 0 | 9 | 9 |
| 2023 January | 0 | 13 | 13 |
| 2022 December | 0 | 6 | 6 |
| 2022 November | 0 | 5 | 5 |
Show all
